Inventor · disambiguated record
Martine Clozel
Also filed as: CLOZEL MARTINE
43 granted patents·18 pending applications·899 citations·filing 1992–2025
98Inventor score
Files withACTELION PHARMACEUTICALS LTD32HOFFMANN LA ROCHE10AISSAOUI HAMED5CLOZEL MARTINE5IDORSIA PHARMACEUTICALS LTD2
Top patents by PatentIndex Score
61 records- 0197US8809334B2Therapeutic compositions containing macitentanCLOZEL MARTINE·Filed 2009·Granted Aug 19, 2014·36 cites·10 claims
- 0295US5292740ASulfonamidesHOFFMANN LA ROCHE·Filed 1992·Granted Mar 8, 1994·180 cites·33 claims
- 0394US7763638B2Substituted 1,2,3,4-tetrahydroisoquinoline derivativesACTELION PHARMACEUTICALS LTD·Filed 2005·Granted Jul 27, 2010·24 cites·6 claims
- 0494US7285549B2Sulfamides and their use as endothelin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2006·Granted Oct 23, 2007·27 cites·5 claims
- 0593US11787782B2Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseasesIDORSIA PHARMACEUTICALS LTD·Filed 2021·Granted Oct 17, 2023·5 cites·39 claims
- 0693US9173881B2Therapeutic compositions containing macitentanACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Nov 3, 2015·8 cites·19 claims
- 0793US8268847B2Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitorCLOZEL MARTINE·Filed 2007·Granted Sep 18, 2012·16 cites·11 claims
- 0893US5420129APhenylsulfonylamide pyrimidineHOFFMANN LA ROCHE·Filed 1993·Granted May 30, 1995·132 cites·14 claims
- 0991US11672783B2Pharmaceutical combination comprising a selective S1P1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2021·Granted Jun 13, 2023·2 cites·15 claims
- 1091US7094781B2Sulfamides and their use as endothelin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2001·Granted Aug 22, 2006·38 cites·11 claims
- 1190US9597331B2Therapeutic compositions containing macitentanACTELION PHARMACEUTICALS LTD·Filed 2015·Granted Mar 21, 2017·3 cites·13 claims
- 1290US7750040B2Thiophene derivativesACTELION PHARMACEUTICALS LTD·Filed 2005·Granted Jul 6, 2010·17 cites·16 claims
- 1389US5541186ASulfonylaminopyrimidinesHOFFMANN LA ROCHE·Filed 1994·Granted Jul 30, 1996·86 cites·23 claims
- 1488US10245253B2Pharmaceutical combination comprising a selective S1P1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2015·Granted Apr 2, 2019·6 cites·12 claims
- 1588US7435815B2Sulfonylamino-acetic acid derivativesACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Oct 14, 2008·10 cites·14 claims
- 1688US5270313ASulfonamides and usesHOFFMANN LA ROCHE·Filed 1992·Granted Dec 14, 1993·81 cites·25 claims
- 1787US11174247B2Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseasesIDORSIA PHARMACEUTICALS LTD·Filed 2017·Granted Nov 16, 2021·6 cites·47 claims
- 1887US11026927B2Pharmaceutical combination comprising a selective S1P1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2019·Granted Jun 8, 2021·4 cites·13 claims
- 1986US2025375426A1Pharmaceutical combination comprising a selective s1p1 receptor agonistVANDA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2085US12409167B2Pharmaceutical combination comprising a selective S1P1 receptor agonistVANDA PHARMACEUTICALS INC·Filed 2023·Granted Sep 9, 2025·0 cites·8 claims
- 2185US2024131009A1Pharmaceutical combination comprising a selective s1p1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 2283US8541433B2Combination comprising macitentan and paclitaxel for treating multi-drug resistant ovarian cancerCLOZEL MARTINE·Filed 2009·Granted Sep 24, 2013·8 cites·4 claims
- 2382US6703392B21,2,3,4-tetrahydroisoquinoline derivativesACTELION PHARMACEUTICALS LTD·Filed 2001·Granted Mar 9, 2004·20 cites·22 claims
- 2481US7868012B2Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseasesACTELION PHARMACEUTICALS LTD·Filed 2005·Granted Jan 11, 2011·4 cites·13 claims
- 2580US7192950B2Benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2001·Granted Mar 20, 2007·15 cites·5 claims
- 2679US7279578B2Sulfonylamino-acetic acid derivativesACTELION PHARMACEUTICALS LTD·Filed 2003·Granted Oct 9, 2007·11 cites·14 claims
- 2777US2021177849A1Therapeutic CompositionsACTELION PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 2876US5837708ASulphonamidesHOFFMANN LA ROCHE·Filed 1996·Granted Nov 17, 1998·21 cites·39 claims
- 2974US7538109B2Quinoxalin-3-one derivatives as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2004·Granted May 26, 2009·7 cites·6 claims
- 3074US5696116APharmaceutical composition which contains a renin angiotensin system inhibitor and an endothelin antagonistHOFFMANN LA ROCHE·Filed 1994·Granted Dec 9, 1997·36 cites·6 claims
- 3174US2020352944A1Therapeutic CompositionsACTELION PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 3272US7452896B2Pyrimidine-sulfamides and their use as endothelian receptor antagonistACTELION PHARMACEUTICALS LTD·Filed 2003·Granted Nov 18, 2008·5 cites·13 claims
- 3372US6004965ASulfonamidesHOFFMANN LA ROCHE·Filed 1995·Granted Dec 21, 1999·32 cites·86 claims
- 3471US2020038401A1Therapeutic CompositionsACTELION PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 3568US6133442AAryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonistsHOFFMANN LA ROCHE·Filed 1999·Granted Oct 17, 2000·22 cites·24 claims
- 3668US2019083494A1Therapeutic CompositionsACTELION PHARMACEUTICALS LTD·Filed 2018·Application pending·0 cites
- 3766US7323465B2Alkansulfonamides as endothelin antagonistsACTELION PHARMACEUTICALS LTD·Filed 2002·Granted Jan 29, 2008·2 cites·9 claims
- 3866US6815451B21,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2002·Granted Nov 9, 2004·2 cites·18 claims
- 3966US2018147205A1Therapeutic CompositionsACTELION PHARMACEUTICALS LTD·Filed 2018·Application pending·0 cites
- 4065US7091201B2Arylalkane-sulfonamides having endothelin-antagonist activityACTELION PHARMACEUTICALS LTD·Filed 2001·Granted Aug 15, 2006·2 cites·14 claims
- 4164US7750161B2Pyridine derivativesBUR DANIEL·Filed 2004·Granted Jul 6, 2010·2 cites·12 claims
- 4264US7375227B2Quinoline derivativesACTELION PHARMACEUTICALS LTD·Filed 2002·Granted May 20, 2008·2 cites·23 claims
- 4364US2014148460A1Therapeutic compositionsCLOZEL MARTINE·Filed 2014·Application pending·0 cites
- 4462US7238685B2Benzo-fused heterocycles as endothelin antagonistsACTELION PHARMACEUTICALS LTD·Filed 2002·Granted Jul 3, 2007·2 cites·12 claims
- 4562US6951856B2Arylethene-sulfonamidesACTELION PHARMACEUTICALS LTD·Filed 2001·Granted Oct 4, 2005·1 cites·38 claims
- 4661US2013210830A9Therapeutic compositionsCLOZEL MARTINE·Filed 2012·Application pending·0 cites
- 4760US11723896B2Pharmaceutical combination comprising ponesimodACTELION PHARMACEUTICALS LTD·Filed 2018·Granted Aug 15, 2023·0 cites·10 claims
- 4857US5962682AAryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonistsHOFFMANN LA ROCHE·Filed 1995·Granted Oct 5, 1999·12 cites·140 claims
- 4956US6596719B16 alkoxy-4-pyrimidinyl bis-sulfonamidesACTELIO PHARMACEUTICALS LTD·Filed 2000·Granted Jul 22, 2003·2 cites·24 claims
- 5053US2004242564A11,2,3,4-tetrahydroisoquinolines derivativesFiled 2004·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Martine Clozel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →